19Indexed trials
mesh condition
Epilepsies, Myoclonic
Intelligence
Epilepsies, Myoclonic intelligence: 19 indexed trials, 6 recruiting studies, 14 sponsors across 17 countries.
6Recruiting
14Sponsors
17Countries
Leading sponsors
Encoded Therapeutics32 recruiting
Jazz Pharmaceuticals31 recruiting
Gillette Children's Specialty Healthcare20 recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10 recruiting
Ionis Pharmaceuticals, Inc.11 recruiting
Longboard Pharmaceuticals10 recruiting
Loulou Foundation11 recruiting
NYU Langone Health10 recruiting
University of Utah10 recruiting
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.10 recruiting
Assistance Publique - Hôpitaux de Paris11 recruiting
Zogenix, Inc.10 recruiting
Geographic activity
United States12trials
Italy5trials
France4trials
United Kingdom4trials
Australia3trials
Canada3trials
Spain3trials
Germany2trials
Japan1trials
Latvia1trials
Mexico1trials
Portugal1trials
Leading interventions
Cannabidiol3trials
ETX1012trials
Fenfluramine Hydrochloride1trials
GWP42003-P1trials
GWP42003-P 10 mg/kg/day Dose1trials
GWP42003-P 20 mg/kg/day Dose1trials
GWP42003-P 5 mg/kg/day Dose1trials
ION3371trials
LP3521trials
Lorcaserin1trials
No intervention; observational1trials
Placebo control1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.